Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes

被引:89
作者
Chen, CPLH
Eastwood, SL
Hope, T
McDonald, B
Francis, PT
Esiri, MM [1 ]
机构
[1] Radcliffe Infirm, Dept Neuropathol, Oxford OX2 6HE, England
[2] Singapore Gen Hosp, Dept Neurol, Singapore 0316, Singapore
[3] Warneford Hosp, Oxford OX3 7JX, England
[4] Univ London Kings Coll, GKT Sch Biomed Sci, Neurosci Res Ctr, London WC2R 2LS, England
关键词
Alzheimer's disease; behavioural changes; immunocytochemistry; neuropathology; raphe nuclei; serotonin;
D O I
10.1046/j.1365-2990.2000.00254.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The dorsal and median raphe nuclei were examined with immunocytochemistry to display the 5-HT neurones in 16 cases of post-mortem-proven Alzheimer's disease (AD) and 12 age and sex-matched controls. The AD cases had been prospectively assessed during life for expression of behavioural changes as well as for cognitive decline. A significant (P<0.001) 41% reduction in density of dorsal raphe neurones was found along with a significant (P<0.02) 29% reduction in density of median raphe neurones in AD. There were significantly more neurofibrillary tangles in both dorsal and median raphe nuclei in AD than in controls (P<0.001). There was no correlation between reduction in neurone density in these nuclei and behavioural change, cognitive decline, neurofibrillary tangle counts in these nuclei or plaque and tangle pathology in frontal and temporal cortex. It was concluded from these findings that the raphe nuclei are significantly affected by the pathology of AD and that plasticity in the 5-HT system is the probable reason for the lack of correlation of reduced 5-HT neurone density and clinical disease parameters.
引用
收藏
页码:347 / 355
页数:9
相关论文
共 51 条
[11]   NUCLEUS RAPHE DORSALIS IN DEMENTIA OF THE ALZHEIMER TYPE - NEUROFIBRILLARY CHANGES AND NEURONAL PACKING DENSITY [J].
CURCIO, CA ;
KEMPER, T .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1984, 43 (04) :359-368
[12]   CLINICAL AND NEUROPATHOLOGICAL CORRELATES OF DEPRESSION IN ALZHEIMERS-DISEASE [J].
FORSTL, H ;
BURNS, A ;
LUTHERT, P ;
CAIRNS, N ;
LANTOS, P ;
LEVY, R .
PSYCHOLOGICAL MEDICINE, 1992, 22 (04) :877-884
[13]   NEUROTRANSMITTERS AND 2ND MESSENGERS IN AGING AND ALZHEIMERS-DISEASE [J].
FRANCIS, PT ;
WEBSTER, MT ;
CHESSELL, IP ;
HOLMES, C ;
STRATMANN, GC ;
PROCTER, AW ;
CROSS, AJ ;
GREEN, AR ;
BOWEN, DM .
ALZHEIMERS DISEASE: AMYLOID PRECUSOR PROTEINS, SIGNAL TRANSDUCTION, AND NEURONAL TRANSPLANTATION, 1993, 695 :19-26
[14]   ALZHEIMERS-DISEASE - NEUROFIBRILLARY TANGLES IN NUCLEI THAT PROJECT TO THE CEREBRAL-CORTEX [J].
GERMAN, DC ;
WHITE, CL ;
SPARKMAN, DR .
NEUROSCIENCE, 1987, 21 (02) :305-312
[15]   IDENTIFICATION OF SEROTONERGIC NEURONS IN HUMAN-BRAIN BY A MONOCLONAL-ANTIBODY BINDING TO ALL 3 AROMATIC AMINO-ACID HYDROXYLASES [J].
HAAN, EA ;
JENNINGS, IG ;
CUELLO, AC ;
NAKATA, H ;
FUJISAWA, H ;
CHOW, CW ;
KUSHINSKY, R ;
BRITTINGHAM, J ;
COTTON, RGH .
BRAIN RESEARCH, 1987, 426 (01) :19-27
[16]   NEUROPATHOLOGY OF IMMUNOHISTOCHEMICALLY IDENTIFIED BRAIN-STEM NEURONS IN PARKINSONS-DISEASE [J].
HALLIDAY, GM ;
LI, YW ;
BLUMBERGS, PC ;
JOH, TH ;
COTTON, RGH ;
HOWE, PRC ;
BLESSING, WW ;
GEFFEN, LB .
ANNALS OF NEUROLOGY, 1990, 27 (04) :373-385
[17]   LOSS OF BRAIN-STEM SEROTONIN-CONTAINING AND SUBSTANCE-P-CONTAINING NEURONS IN PARKINSONS-DISEASE [J].
HALLIDAY, GM ;
BLUMBERGS, PC ;
COTTON, RGH ;
BLESSING, WW ;
GEFFEN, LB .
BRAIN RESEARCH, 1990, 510 (01) :104-107
[18]  
HALLIDAY GM, 1992, ACTA NEUROPATHOL, V84, P638
[19]   ALZHEIMERS NEUROFIBRILLARY CHANGES - A TOPOGRAPHIC STUDY [J].
HIRANO, A ;
ZIMMERMAN, HM .
ARCHIVES OF NEUROLOGY, 1962, 7 (03) :227-+
[20]   Apolipoprotein E: Depressive illness, depressive symptoms, and Alzheimer's disease [J].
Holmes, C ;
Russ, C ;
Kirov, G ;
Aitchison, KJ ;
Powell, JF ;
Collier, DA ;
Lovestone, S .
BIOLOGICAL PSYCHIATRY, 1998, 43 (03) :159-164